The combined GnRH-agonist and intrauterine levonorgestrel-releasing system treatment of complicated atypical hyperplasia and endometrial cancer: a pilot study

By Pashov Alexandr I.   Tskhay Vitaly B.   Ionouchene Svetlana V.  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 559-561

Informa Healthcare

Access to resources Recommend Favorite

Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study

By Lewin A.   Pisov G.   Turgeman R.   Fatum M.   Shufaro Y.   Simon A.   Laufer N.   Revel A.   Reubinoff B.   Safran A.  

Gynecological Endocrinology, Vol. 16, Iss. 2, 2002-04 ,pp. : 131-136

Informa Healthcare

Access to resources Recommend Favorite

The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use

By Pengdi Z   Xiaoqun L   Hongzhi L   Zhao G   Jie C   Ruhua X   Shizhu L   Shangchun W   Jiedong W  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 970-975

Oxford University Press

Access to resources Recommend Favorite

Effects of α and β recombinant FSH (Gonal-F, Puregon) and progesterone upon human endometrial cell proliferation in-vitro: a preliminary study

By Chang Chi-Chen   Hsieh Yao-Yuan   Hsu Kung-Hao   Lin Chih-Sheng  

Gynecological Endocrinology, Vol. 27, Iss. 2, 2011-02 ,pp. : 110-116

Informa Healthcare

Access to resources Recommend Favorite

The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study

By  

Cerebrovascular Diseases, Vol. 20, Iss. 5, 2005-11 ,pp. : 304-309

Karger

Access to resources Recommend Favorite